EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
G1+G2
Kees Neef (on Wed 21st March), Ana Valladolid (on Thu 22nd March)
Linked to EAHP Statements
Section 1 – Introductory Statements and Governance: Statements 1.1, 1.3, 1.5
Section 3 – Production and compounding: Statements 3.2, 3.3, 3.4
Section 5 – Patient Safety and Quality Assurance: Statements 5.1, 5.2, 5.6, 5.11
ACPE UAN: 0475-0000-18-016-L04-P. A knowledge based activity.
Abstract
One of the major promises of mergers of multinational enterprises and of regionally assembled hospitals is the presumed economical advantage induced by scaling up and centralisation of manufacturing lines. However, new vulnerabilities are emerging in terms of quality and supply. The reliability on an undisrupted supply of medicinal products is even more in danger if hospital production is restricted because of such mergers as well. Further objectives of mergers such as reaching critical masses of patient cases and of economy of scale may critically enhance risks for patient care and patient safety.
This seminar will shed light on clinical and quality of life outcomes as compared to the financial goals of hospital mergers.
Learning objectives
After the session, the participant should be able to:
• Assess the ratio between objectives and outcomes of hospital mergers, as well as technical approaches and workload to human resources implied;
• Identify challenges to hospital pharmacies in the course of mergers;
• Apply coping strategies for undesirable effects of hospital mergers;
• Evaluate theoretical and real outcomes of hospital mergers in terms of clinical, financial, and patients’ quality of life; and
• Apply coping strategies for debugging and troubleshooting procedural shortcomings.
Educational need addressed
Although the economy of scale is repeatedly used as justification to produce big numbers of units in highly-developed technological environments, hospital pharmacist were forced to observe changes and reengineering measures combined with disappearance of the flexible polyvalent hospital pharmacy production. Today, hospital pharmacy is facing shortages, supply chain disruptions and an insane dependence on others. This brings loss of time and deterioration in provision of medicines to patients which could be basically easily produced in a short time in a hospital. The hospital pharmacist is interested in fact and figures about obtained added values or failures to reach the declared aims of mergers.
Keywords: production, merger, clinical services, pitfalls/risks
